BY MARKETWIRE
-
Citi not surprised by Trump’s end to obesity drug reimbursement
The proposition was made by previous head of state Joe Biden, regarding 3 weeks after he shed the United States governmental political election to Donald Trump.
-
US halt to obesity drug reimbursement disappoints Novo Nordisk and Eli Lilly
According to Novo Nordisk, it is critical that the United States health and wellness authorities select to control “based on existing clinical scientific research”.
-
Lundbeck to present “positive” epilepsy data from study at upcoming conference
According to Lundbeck, information for the epilepsy prospect bexicaserin reveal a steady safety and security account and tolerability.
-
William Demant Invest continues to lose on GN after large decline last year
Numerous of the investment firm’s endeavors experienced decreases in 2015. The adverse pattern proceeds for GN in 2025, to name a few.
-
EU pharma sector can handle Trump’s tariffs, says JPMorgan
Donald Trump has actually continuously revealed tolls on pharmaceutical items.
-
Danske Bank on Lundbeck’s migraine candidate update: Very disappointing
Lundbeck increases its stage 2b research study with its migraine prospect with intravenous application. Danske Financial institution claims this will certainly decrease the industr…
-
FDA approves new version of Bavarian Nordic’s smallpox and mpox vaccine
The brand-new variation supplies a variety of benefits in regards to transport, storage space problems and sturdiness.
-
Genmab gets European approval for cervical cancer treatment
The authorization covers therapy of innovative or recurring cervical cancer cells and is the only accepted antibody treatment in the EU, according to Genmab
-
Demant boss takes “one day at a time” amid trade war unpredictability
To name a few points, the listening devices supplier, which has a big manufacturing facility in Tijuana, maintains a close eye on tolls on Mexican products.
-
Novo Nordisk nearing worst trading month since 2002
The Novo Nordisk share rate has actually dropped by as much as 28% in the previous month.